首页> 美国卫生研究院文献>Immunology >Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components C1q and C3-C3b.
【2h】

Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components C1q and C3-C3b.

机译:可溶性免疫复合物与Raji淋巴细胞的结合。受体对补体成分C1q和C3-C3b的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have found that, although the binding of particulate antigen-antibody complement complexes such as EAC to lymphoblastoid Raji cells is mediated largely through receptors for C3b, the binding of complement-containing soluble complexes such as those prepared with aggregated human IgG (AHG) occurs also via receptors for C1q. Evidence supporting this conclusion included: (1) Binding of AHG to Raji cells takes place after incubation in EDTA serum; (2) Binding of AHG does not occur in C1q deficient EDTA serum but does take place after addition of C1q; (3) The extent of binding of AHG in EDTA serum is a function of the amount of C1q present; (4) Raji cells can bind up to 5-4 times 10(5) molecules of 125I C1q per cell which can be blocked by unlabelled C1q; (5) AHG pre-incubated with C can bind to a T-cell line MOLT, which lacks receptors for C3b but possesses receptors for C1q to the same extent as Raji cells; (6) Immunoassays for immune complexes in human sera yield similar results whether Raji cells, MOLT cells or C1q precipitation is used for assay; (7) EAC-Raji cell rosettes can be inhibited with inulin-treated, C1q deficient serum containing C3b or C3d whereas binding of AHG or immune complexes in patient samples to Raji or MOLT cells is not inhibited by this reagent. We conclude that receptors for C1q on certain B and T lymphocytes may play an important role in physiologic functions of lymphocytes depending on binding of soluble immune complexes to their surfaces.
机译:我们已经发现,尽管颗粒抗原-抗体补体复合物(例如EAC)与淋巴母细胞Raji细胞的结合主要是通过C3b受体介导的,但仍会发生含补体的可溶性复合物(例如用聚集的人IgG(AHG)制备的结合物)的结合。也通过C1q的受体。支持该结论的证据包括:(1)在EDTA血清中孵育后,发生了AHG与Raji细胞的结合; (2)AHG的结合在缺乏C1q的EDTA血清中不会发生,但会在添加C1q之后发生。 (3)EDTA血清中AHG的结合程度是存在的C1q量的函数; (4)Raji细胞最多可结合每细胞10(5)个125I C1q分子的5-4倍,可被未标记的C1q阻断; (5)与C预孵育的AHG可以与T细胞系MOLT结合,后者缺乏C3b受体,但具有与Raji细胞相同程度的C1q受体; (6)无论是使用Raji细胞,MOLT细胞还是C1q沉淀进行人体血清免疫复合物免疫分析,结果均相似。 (7)EAC-Raji细胞花环可以用菊粉处理过的,含有C3b或C3d的C1q缺陷型血清抑制,而患者样品中的AHG或免疫复合物与Raji或MOLT细胞的结合不受该试剂的抑制。我们得出的结论是,取决于可溶性免疫复合物与其表面的结合,某些B和T淋巴细胞上C1q的受体可能在淋巴细胞的生理功能中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号